US Stock MarketDetailed Quotes

DVA DaVita

Watchlist
  • 145.950
  • +2.970+2.08%
Close Feb 26 16:00 ET
  • 145.950
  • 0.0000.00%
Post 20:01 ET
11.68BMarket Cap13.60P/E (TTM)

About DaVita Company

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Company Profile

SymbolDVA
Company NameDaVita
Listing DateOct 30, 1995
Issue Price15.50
Founded1994
CEOMr. Javier J. Rodriguez
MarketNYSE
Employees76000
Fiscal Year Ends12-31
Address2000 16th Street
CityDenver
ProvinceColorado
CountryUnited States of America
Zip Code80202-7198
Phone1-720-631-2100

Company Executives

  • Name
  • Position
  • Salary
  • Javier J. Rodriguez
  • Director and Chief Executive Officer
  • 6.71M
  • James O. Hearty
  • Chief Compliance Officer
  • 2.73M
  • Kathleen Alyce Waters
  • Chief Legal and Public Affairs Officer
  • 5.61M
  • Joel Ackerman
  • Chief Financial Officer and Treasurer
  • 6.87M
  • Michael David Staffieri
  • Chief Operating Officer Emeritus
  • 10.42M
  • Christopher M. Berry
  • Chief Accounting Officer
  • --
  • David P. Maughan
  • Chief Operating Officer, DaVita Kidney Care
  • --
  • Pamela M. Arway
  • Chairman of the Board
  • 497.46K
  • Dennis W. Pullin
  • Director
  • --
  • Phyllis R. Yale
  • Independent Director
  • 374.96K
  • Wendy L. Schoppert
  • Independent Director
  • 106.86K
  • Adam H. Schechter
  • Independent Director
  • 334.96K
  • Barbara J. Desoer
  • Independent Director
  • 384.96K
  • Charles G. Berg
  • Independent Director
  • 322.46K
  • Gregory J Moore
  • Independent Director
  • 355.89K
  • Jason M. Hollar
  • Independent Director
  • 364.96K

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More